| Quinn Patterson, | |
|
4175 N Hanson Ct, Bowie, MD 20716-3179 | |
| (443) 481-1140 | |
| Not Available |
| Full Name | Quinn Patterson |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 6 Years |
| Location | 4175 N Hanson Ct, Bowie, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518451731 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ati Holdings Llc | 9537112719 | 375 |
News Archive
BMJ News Examines Ongoing EU-India Trade Talks' Impact On Access To Affordable Medicines
High levels of self-certainty, one aspect of cognitive insight, are associated with the presence of delusional symptoms in people with at-risk mental states, a study shows.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
In this post in KPLU 88.5's "Humanosphere" blog, journalist Tom Murphy interviews reporter Jonathan Katz, "the first to break the story connecting U.N. peacekeepers from Nepal to the" cholera outbreak in Haiti.
› Verified 4 days ago
| Provider Name | Ati Holdings Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396781050 PECOS PAC ID: 9537112719 Enrollment ID: O20061020000349 |
News Archive
BMJ News Examines Ongoing EU-India Trade Talks' Impact On Access To Affordable Medicines
High levels of self-certainty, one aspect of cognitive insight, are associated with the presence of delusional symptoms in people with at-risk mental states, a study shows.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
In this post in KPLU 88.5's "Humanosphere" blog, journalist Tom Murphy interviews reporter Jonathan Katz, "the first to break the story connecting U.N. peacekeepers from Nepal to the" cholera outbreak in Haiti.
› Verified 4 days ago
| Provider Name | Ati Holdings Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1396781050 PECOS PAC ID: 9537112719 Enrollment ID: O20061023000321 |
News Archive
BMJ News Examines Ongoing EU-India Trade Talks' Impact On Access To Affordable Medicines
High levels of self-certainty, one aspect of cognitive insight, are associated with the presence of delusional symptoms in people with at-risk mental states, a study shows.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
In this post in KPLU 88.5's "Humanosphere" blog, journalist Tom Murphy interviews reporter Jonathan Katz, "the first to break the story connecting U.N. peacekeepers from Nepal to the" cholera outbreak in Haiti.
› Verified 4 days ago
| Provider Name | Orthopedic Physicians Of Annapolis Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780824615 PECOS PAC ID: 9032269154 Enrollment ID: O20090611000485 |
News Archive
BMJ News Examines Ongoing EU-India Trade Talks' Impact On Access To Affordable Medicines
High levels of self-certainty, one aspect of cognitive insight, are associated with the presence of delusional symptoms in people with at-risk mental states, a study shows.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
In this post in KPLU 88.5's "Humanosphere" blog, journalist Tom Murphy interviews reporter Jonathan Katz, "the first to break the story connecting U.N. peacekeepers from Nepal to the" cholera outbreak in Haiti.
› Verified 4 days ago
| Provider Name | Lhmg Physical Therapy, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1396122842 PECOS PAC ID: 3870893738 Enrollment ID: O20151201000903 |
News Archive
BMJ News Examines Ongoing EU-India Trade Talks' Impact On Access To Affordable Medicines
High levels of self-certainty, one aspect of cognitive insight, are associated with the presence of delusional symptoms in people with at-risk mental states, a study shows.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
In this post in KPLU 88.5's "Humanosphere" blog, journalist Tom Murphy interviews reporter Jonathan Katz, "the first to break the story connecting U.N. peacekeepers from Nepal to the" cholera outbreak in Haiti.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Quinn Patterson, 9314 Ispahan Loop, Laurel, MD 20708-2853 Ph: (301) 520-7836 | Quinn Patterson, 4175 N Hanson Ct, Bowie, MD 20716-3179 Ph: (443) 481-1140 |
News Archive
BMJ News Examines Ongoing EU-India Trade Talks' Impact On Access To Affordable Medicines
High levels of self-certainty, one aspect of cognitive insight, are associated with the presence of delusional symptoms in people with at-risk mental states, a study shows.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.
In this post in KPLU 88.5's "Humanosphere" blog, journalist Tom Murphy interviews reporter Jonathan Katz, "the first to break the story connecting U.N. peacekeepers from Nepal to the" cholera outbreak in Haiti.
› Verified 4 days ago
Alexa Archambeault, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6915 Laurel Bowie Rd Ste 205, Bowie, MD 20715 Phone: 240-245-4370 | |
Ms. Nikya Yadira Anderson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 417 Jordon Pond Ln, Bowie, MD 20721 Phone: 301-646-6773 Fax: 301-249-9161 | |
Ms. Alia Bland Epps, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 903 Jennings Mill Dr, Bowie, MD 20721 Phone: 240-832-4959 | |
Ms. Brittany Whaley-jubilee, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15005 Health Center Dr, Bowie, MD 20716 Phone: 301-805-6070 | |
Lea Curcio, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14997 Health Center Dr, Bowie, MD 20716 Phone: 301-464-4400 | |
Mr. Devon Irvin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1723 Stourbridge Ct, Bowie, MD 20721 Phone: 202-320-7386 | |
Mrs. Kaitlin Zurbruegg, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 4175 N Hanson Ct Ste 301, Bowie, MD 20716 Phone: 443-481-1140 |